| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
41,504,000 |
| Market
Cap: |
1.23(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$24.67 - $41.86 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 572 |
| Guru Rank Value : 3.2 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Collegium Pharmaceutical is a pharmaceutical company. Co.'s portfolio includes: Xtampza ER, Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol. Xtampza ER was approved by the U.S. Food and Drug Administration for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. Nucynta ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy in adults. Nucynta IR is indicated for the management of acute pain severe enough to require an opioid analgesic.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
6,601 |
202,125 |
231,943 |
546,934 |
| Total Sell Value |
$202,149 |
$5,997,077 |
$7,122,189 |
$17,238,443 |
| Total People Sold |
1 |
4 |
5 |
7 |
| Total Sell Transactions |
1 |
18 |
21 |
34 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Freund John Gordon |
Director |
– • – |
2025-06-09 |
4 |
S |
$30.62 |
$202,149 |
D/D |
(6,601) |
70,658 |
|
2% |
|
| Freund John Gordon |
Director |
– • – |
2025-06-09 |
4 |
OE |
$13.45 |
$201,750 |
D/D |
15,000 |
77,259 |
|
- |
|
| Bohlin Garen G |
Director |
– • – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,791 |
62,259 |
|
- |
|
| Lurker Nancy |
Director |
– • – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,791 |
22,517 |
|
- |
|
| Freund John Gordon |
Director |
– • – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,791 |
62,259 |
|
- |
|
| Santini Gino |
Director |
– • – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,791 |
85,447 |
|
- |
|
| Fallon John A. |
Director |
– • – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,791 |
64,634 |
|
- |
|
| Paya Carlos V |
Director |
– • – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
19,582 |
19,582 |
|
- |
|
| Balice-Gordon Rita J. |
Director |
– • – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,791 |
56,279 |
|
- |
|
| Dreyer Scott |
EVP & Chief Commercial Officer |
• – – |
2025-03-21 |
4 |
AS |
$30.03 |
$566,983 |
D/D |
(18,881) |
103,613 |
|
-0% |
|
| Tupper Colleen |
EVP & Chief Financial Officer |
• – – |
2025-03-21 |
4 |
AS |
$30.03 |
$192,069 |
D/D |
(6,396) |
156,667 |
|
-0% |
|
| Dreyer Scott |
EVP & Chief Commercial Officer |
• – – |
2025-03-20 |
4 |
AS |
$30.00 |
$57,811 |
D/D |
(1,927) |
122,494 |
|
- |
|
| Tupper Colleen |
EVP & Chief Financial Officer |
• – – |
2025-03-20 |
4 |
AS |
$30.00 |
$36,181 |
D/D |
(1,206) |
163,063 |
|
- |
|
| Dieter David |
EVP & General Counsel |
• – – |
2025-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
68,449 |
68,449 |
|
- |
|
| Dreyer Scott |
EVP & Chief Commercial Officer |
• – – |
2025-03-14 |
4 |
AS |
$30.00 |
$67,661 |
D/D |
(2,255) |
124,421 |
|
2% |
|
| Tupper Colleen |
EVP & Chief Financial Officer |
• – – |
2025-03-14 |
4 |
AS |
$30.00 |
$29,313 |
D/D |
(977) |
164,269 |
|
2% |
|
| Dreyer Scott |
EVP & Chief Commercial Officer |
• – – |
2025-03-11 |
4/A |
AS |
$30.00 |
$461,672 |
D/D |
(15,387) |
126,676 |
|
- |
|
| Tupper Colleen |
EVP & Chief Financial Officer |
• – – |
2025-03-11 |
4 |
AS |
$30.01 |
$313,413 |
D/D |
(10,445) |
165,246 |
|
-0% |
|
| Dreyer Scott |
EVP & Chief Commercial Officer |
• – – |
2025-03-07 |
4 |
AS |
$30.00 |
$70,446 |
D/D |
(2,348) |
142,063 |
|
4% |
|
| Tupper Colleen |
EVP & Chief Financial Officer |
• – – |
2025-03-07 |
4 |
AS |
$30.00 |
$45,121 |
D/D |
(1,504) |
175,691 |
|
4% |
|
| Dreyer Scott |
EVP & Chief Commercial Officer |
• – – |
2025-03-06 |
4 |
AS |
$30.00 |
$461,672 |
D/D |
(15,387) |
126,676 |
|
0% |
|
| Dreyer Scott |
EVP & Chief Commercial Officer |
• – – |
2025-03-06 |
4 |
AS |
$30.00 |
$98,854 |
D/D |
(3,295) |
144,411 |
|
0% |
|
| Tupper Colleen |
EVP & Chief Financial Officer |
• – – |
2025-03-06 |
4 |
AS |
$30.00 |
$58,470 |
D/D |
(1,949) |
177,195 |
|
0% |
|
| Kuhlmann Shirley R. |
EVP and General Counsel |
• – – |
2025-03-06 |
4 |
S |
$28.50 |
$742,946 |
D/D |
(26,067) |
108,137 |
|
-0% |
|
| Kuhlmann Shirley R. |
EVP and General Counsel |
• – – |
2025-03-05 |
4 |
S |
$28.03 |
$560,528 |
D/D |
(20,000) |
134,204 |
|
-5% |
|
432 Records found
|
|
Page 1 of 18 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.36 (1.2%) 
